Vipibax - About the company
Vipibax is a public company based in Germany, founded in 2017. It operates as a Developer of animal health products, including diagnostic tests and treatments. The company has 76 active competitors, including 5 funded and 6 that have exited. Its top competitors include companies like Pictor, Heska and Biotangents.
Company Details
Developer of animal health products, including diagnostic tests and treatments. The company provides solutions for the detection and treatment of specific animal ailments. It offers diagnostic testing services alongside therapeutic products. The focus is on supporting animal well-being through targeted healthcare interventions.
- Website
- vipibax.de
Key Metrics
Founded Year
2017
Location
Stage
Public
Ranked
44th among 76 active competitors
Employee Count
2 as on Apr 30, 2026
Exit Details
Public
Sign up to download Vipibax's company profile
Vipibax's funding and investors
Vipibax has not raised any funding rounds yet.
Vipibax's founders and board of directors
Founder? Claim ProfileVipibax's employee count trend
Vipibax has 2 employees as of Apr 26. Here is Vipibax's employee count trend over the years:
Access Tracxn on any website
Install Tracxn ExtensionOur Google Chrome extension lets you view company details while browsing their websites
Vipibax's Competitors and alternates
Top competitors of Vipibax include Pictor, Heska and Biotangents. Here is the list of Top 10 competitors of Vipibax, ranked by Tracxn score:
Get insights and benchmarks for competitors of 2M+ companies! Sign up today!
Rank | Company Details | Short Description | Total Funding | Investors | Tracxn Score |
|---|---|---|---|---|---|
1st | Pictor 2005, Auckland (New Zealand), Series A | Developer of immunodiagnostic products based on multiplexed assays | $11.1M | 60/100 | |
2nd | Heska 1988, Fort Collins (United States), Acquired | Provider of diagnostic solutions for pet care | $10.1M | - | 56/100 |
3rd | Biotangents 2015, Edinburgh (United Kingdom), Series A | Developer of diagnostic assays for infectious diseases in veterinary medicine | $5.62M | 45/100 | |
4th | 5Strands 2018, Lawrenceville (United States), Unfunded | Provider of diagnostic test for determining temporary imbalances for food and environmental intolerance | - | - | 41/100 |
5th | Online platform to book diagnostic services for pets | - | 39/100 | ||
6th | Provider of genetic testing services for pet animals | - | - | 39/100 | |
7th | Silver Lake Research 1993, Azusa (United States), Funding Raised | Innovating rapid diagnostics with EAP™-derived antibodies for point-of-care testing | - | 34/100 | |
8th | InsectSense 2020, Wageningen (Netherlands), Seed | Developer of insect-based technology for the diagnosis of plant and animal diseases | $824K | 32/100 | |
9th | Provider of novel therapeutics products and services for animal health | - | 31/100 | ||
10th | Bionote 2019, Big Lake (United States), Funding Raised | Provider of point-of-care testing devices for animal health | - | 31/100 | |
44th | Developer of animal health products, including diagnostic tests and treatments | - | - | 21/100 |
Looking for more details on Vipibax's competitors? Click here to see the top ones
Vipibax's Investments and acquisitions
Vipibax has made no investments or acquisitions yet.
Reports related to Vipibax
Here is the latest report on Vipibax's geography:
Are you a Founder ?
FAQs about Vipibax
Explore our recently published companies
- Robbins-Aviation - Scottsbluff based, 2017 founded, Unfunded company
- Asetaviation - Unfunded company
- Dreamsaviationacademy - Unfunded company
- Dronshop - Unfunded company
- Aam Link - Unfunded company
- Grandlajja - India based, 2020 founded, Unfunded company